Oppenheimer analyst Mitchel Penn raised the firm’s price target on Hercules Capital to $15 from $13 and keeps a Perform rating on the shares. The firm estimates that Hercules can earn $2.35/share and $2.00/share in 2023 and 2024, respectively, for an ROE of 22.1% and 17.3%, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HTGC:
- Hercules Capital reports Q2 NII 53c, consensus 49c
- X4 Pharmaceuticals closes $115M loan facility with Hercules Capital
- Hercules Capital raises Q2 total cash distribution to 48c per share
- Hercules Technology Growth Capital (HTGC) Q2 Earnings Cheat Sheet
- Heron Therapeutics sells 20.73M shares at $1.37 in private placement